effect of ovarian stimulation drugs on incidance of unruptured follicle

Not Applicable

• Conditions: Condition 1: luteinized unruptured follicle. Condition 2: luteinized unruptured follicle.; Female infertility associated with anovulation; Female infertility, unspecified

• Registration Number: IRCT2014091019113N1
• Lead Sponsor: Tehran University Of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 180

Inclusion Criteria

1-infertile women 18-35years old candidate for IUI
2-infertility causes:pco,unexplained infertility,male factor
Exclusion criteria:
1-hyper prolactinemia,hypo and hyperthyroidism,ovarian cyst,NSAID users,uterus and tubal malfprmation
2-OHSS

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
uteinized unruptured follicle. Timepoint: 5-6 days after IUI. Method of measurement: sonography+ serum progesterone( ng/ml).

Secondary Outcome Measures

Name	Time	Method
Follicular size. Timepoint: every other day from 10 day of cycle. Method of measurement: vaginal sonography.;Serum progesterone. Timepoint: 5-6 days after IUI. Method of measurement: blood test.;Ovulation. Timepoint: before and 5-6 days after IUI,. Method of measurement: vaginal sonography.;Pregnancy. Timepoint: 14days after IUI. Method of measurement: ßhcg blood test.;FSH. Timepoint: 2-3 day of cycle before included in stydy. Method of measurement: blood test.;Infertility cause. Timepoint: before included in study. Method of measurement: clinician judgement.;Endometrial thickness. Timepoint: every other day from 10 day of cycle. Method of measurement: vaginal sonography.;LH. Timepoint: 2-3day of cycle before included in study. Method of measurement: blood test.